Telesis Bio, Inc. (TBIO)
OTCMKTS
· Delayed Price · Currency is USD
0.0500
0.00 (0.00%)
Jun 12, 2025, 8:00 PM EDT
Telesis Bio Market Cap
Telesis Bio has a market cap or net worth of $90.09 thousand as of June 13, 2025. Its market cap has decreased by -99.30% in one year.
Market Cap
90.09K
Enterprise Value
42.96M
Revenue
17.03M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since June 18, 2021, Telesis Bio's market cap has decreased from 522.24M to 90.09K, a decrease of -99.98%. That is a compound annual growth rate of -88.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2025 | 90.09K | -87.32% |
| Dec 31, 2024 | 710.34K | -94.06% |
| Dec 29, 2023 | 11.96M | -66.23% |
| Dec 30, 2022 | 35.43M | -88.81% |
| Dec 31, 2021 | 316.52M | -39.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.59B |
| Veradigm | 764.23M |
| Elite Pharmaceuticals | 717.88M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 637.25M |
| CytoDyn | 441.29M |
| Northwest Biotherapeutics | 403.72M |
| Glass House Brands | 384.13M |